Myriad Genetics Inc (MYGN)
19.58
-0.22
(-1.11%)
USD |
NASDAQ |
Apr 30, 16:00
19.58
0.00 (0.00%)
After-Hours: 20:00
Myriad Genetics Net Income (Quarterly): -31.20M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -31.20M |
| September 30, 2023 | -61.30M |
| June 30, 2023 | -116.10M |
| March 31, 2023 | -54.70M |
| December 31, 2022 | -42.30M |
| September 30, 2022 | -35.10M |
| June 30, 2022 | -14.10M |
| March 31, 2022 | -20.50M |
| December 31, 2021 | -7.60M |
| September 30, 2021 | 24.60M |
| June 30, 2021 | -4.70M |
| March 31, 2021 | -39.50M |
| September 30, 2020 | -15.20M |
| June 30, 2020 | -55.40M |
| March 31, 2020 | -115.20M |
| December 31, 2019 | -8.30M |
| September 30, 2019 | -20.60M |
| June 30, 2019 | -4.20M |
| March 31, 2019 | 6.90M |
| December 31, 2018 | 2.60M |
| September 30, 2018 | -0.70M |
| June 30, 2018 | 14.40M |
| March 31, 2018 | 9.10M |
| December 31, 2017 | 30.90M |
| September 30, 2017 | 78.80M |
| Date | Value |
|---|---|
| June 30, 2017 | 8.40M |
| March 31, 2017 | 4.20M |
| December 31, 2016 | 5.90M |
| September 30, 2016 | -1.20M |
| June 30, 2016 | 15.20M |
| March 31, 2016 | 34.50M |
| December 31, 2015 | 37.10M |
| September 30, 2015 | 30.30M |
| June 30, 2015 | 18.70M |
| March 31, 2015 | 21.40M |
| December 31, 2014 | 24.00M |
| September 30, 2014 | 16.00M |
| June 30, 2014 | 33.61M |
| March 31, 2014 | 36.77M |
| December 31, 2013 | 50.36M |
| September 30, 2013 | 55.46M |
| June 30, 2013 | 44.14M |
| March 31, 2013 | 37.89M |
| December 31, 2012 | 35.04M |
| September 30, 2012 | 30.14M |
| June 30, 2012 | 29.14M |
| March 31, 2012 | 29.62M |
| December 31, 2011 | 28.30M |
| September 30, 2011 | 25.10M |
| June 30, 2011 | 26.04M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-116.10M
Minimum
Jun 2023
24.60M
Maximum
Sep 2021
-34.52M
Average
-25.90M
Median
Net Income (Quarterly) Benchmarks
| Stryker Corp | 1.143B |
| Perspective Therapeutics Inc | -24.68M |
| Electromed Inc | 1.674M |
| Xtant Medical Holdings Inc | -4.303M |
| Asensus Surgical Inc | -17.24M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 196.60M |
| Total Expenses (Quarterly) | 115.20M |
| EPS Diluted (Quarterly) | -0.36 |
| Enterprise Value | 1.677B |
| Gross Profit Margin (Quarterly) | 68.67% |
| Profit Margin (Quarterly) | -15.87% |
| Earnings Yield | -16.34% |
| Normalized Earnings Yield | -9.903 |